FBT
VIVO

First Bank & Trust’s Meridian Bioscience Inc VIVO Stock Holding History

First Bank & Trust’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,231
Closed -$159K – 526
2022
Q2 		$159K Buy
5,231
+1,912
+58% +$51.7K 0.05% 199
2022
Q1 		$86K Sell
3,319
-1,437
-30% -$34.2K 0.03% 265
2021
Q4 		$97K Buy
4,756
+336
+8% +$6.44K 0.04% 240
2021
Q3 		$85K Hold
4,420
– – 0.04% 244
2021
Q2 		$98K Buy
4,420
+2,980
+207% +$63.2K 0.05% 232
2021
Q1 		$38K Buy
+1,440
New +$34.2K 0.02% 283

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Bank & Trust's VIVO Position: Q3 2022 in Review

First Bank & Trust sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 5,231 shares — an estimated $159K sold.

First Bank & Trust first reported a position in VIVO in Q1 2021 and held it in 6 quarters. The position peaked at $159K in Q2 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • First Bank & Trust reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • First Bank & Trust sold 5,231 Meridian Bioscience Inc shares in Q3 2022, an estimated $159K.
  • First Bank & Trust first reported a position in Meridian Bioscience Inc in Q1 2021 and held it in 6 quarters.
  • First Bank & Trust's Meridian Bioscience Inc position peaked at $159K in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on First Bank & Trust's 13F filing for Q3 2022, filed 28 Oct 2022.